List of Tables
Table 1. Multidrug Resistant Bacteria Treatment Market Trends
Table 2. Multidrug Resistant Bacteria Treatment Market Drivers & Opportunity
Table 3. Multidrug Resistant Bacteria Treatment Market Challenges
Table 4. Multidrug Resistant Bacteria Treatment Market Restraints
Table 5. Global Multidrug Resistant Bacteria Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Multidrug Resistant Bacteria Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Multidrug Resistant Bacteria Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Multidrug Resistant Bacteria Treatment
Table 10. Global Multidrug Resistant Bacteria Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multidrug Resistant Bacteria Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Multidrug Resistant Bacteria Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Multidrug Resistant Bacteria Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Multidrug Resistant Bacteria Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Multidrug Resistant Bacteria Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Multidrug Resistant Bacteria Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Multidrug Resistant Bacteria Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Multidrug Resistant Bacteria Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Multidrug Resistant Bacteria Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Multidrug Resistant Bacteria Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Multidrug Resistant Bacteria Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Multidrug Resistant Bacteria Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Multidrug Resistant Bacteria Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Multidrug Resistant Bacteria Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Multidrug Resistant Bacteria Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Multidrug Resistant Bacteria Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Multidrug Resistant Bacteria Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Multidrug Resistant Bacteria Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Multidrug Resistant Bacteria Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Nabriva Therapeutics Basic Information List
Table 32. Nabriva Therapeutics Description and Business Overview
Table 33. Nabriva Therapeutics Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Nabriva Therapeutics (2019-2024)
Table 35. Nabriva Therapeutics Recent Developments
Table 36. BioVersys Basic Information List
Table 37. BioVersys Description and Business Overview
Table 38. BioVersys Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of BioVersys (2019-2024)
Table 40. BioVersys Recent Developments
Table 41. Johnson & Johnson Basic Information List
Table 42. Johnson & Johnson Description and Business Overview
Table 43. Johnson & Johnson Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Johnson & Johnson (2019-2024)
Table 45. Johnson & Johnson Recent Developments
Table 46. Destiny Pharma Basic Information List
Table 47. Destiny Pharma Description and Business Overview
Table 48. Destiny Pharma Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Destiny Pharma (2019-2024)
Table 50. Destiny Pharma Recent Developments
Table 51. Armata Pharmaceuticals Basic Information List
Table 52. Armata Pharmaceuticals Description and Business Overview
Table 53. Armata Pharmaceuticals Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Armata Pharmaceuticals (2019-2024)
Table 55. Armata Pharmaceuticals Recent Developments
Table 56. Westway Health Basic Information List
Table 57. Westway Health Description and Business Overview
Table 58. Westway Health Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Westway Health (2019-2024)
Table 60. Westway Health Recent Developments
Table 61. Nemesis Bioscience Basic Information List
Table 62. Nemesis Bioscience Description and Business Overview
Table 63. Nemesis Bioscience Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Nemesis Bioscience (2019-2024)
Table 65. Nemesis Bioscience Recent Developments
Table 66. Tetraphase Pharmaceuticals Basic Information List
Table 67. Tetraphase Pharmaceuticals Description and Business Overview
Table 68. Tetraphase Pharmaceuticals Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Tetraphase Pharmaceuticals (2019-2024)
Table 70. Tetraphase Pharmaceuticals Recent Developments
Table 71. Allergan Basic Information List
Table 72. Allergan Description and Business Overview
Table 73. Allergan Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Allergan (2019-2024)
Table 75. Allergan Recent Developments
Table 76. Merck Basic Information List
Table 77. Merck Description and Business Overview
Table 78. Merck Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Merck (2019-2024)
Table 80. Merck Recent Developments
Table 81. Pfizer Basic Information List
Table 82. Pfizer Description and Business Overview
Table 83. Pfizer Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Pfizer (2019-2024)
Table 85. Pfizer Recent Developments
Table 86. CARB-X Basic Information List
Table 87. CARB-X Description and Business Overview
Table 88. CARB-X Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of CARB-X (2019-2024)
Table 90. CARB-X Recent Developments
Table 91. Melinta Therapeutics Basic Information List
Table 92. Melinta Therapeutics Description and Business Overview
Table 93. Melinta Therapeutics Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Melinta Therapeutics (2019-2024)
Table 95. Melinta Therapeutics Recent Developments
Table 96. Novartis Basic Information List
Table 97. Novartis Description and Business Overview
Table 98. Novartis Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 99. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Novartis (2019-2024)
Table 100. Novartis Recent Developments
Table 101. Vertex Pharmaceuticals Incorporated Basic Information List
Table 102. Vertex Pharmaceuticals Incorporated Description and Business Overview
Table 103. Vertex Pharmaceuticals Incorporated Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 104. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Vertex Pharmaceuticals Incorporated (2019-2024)
Table 105. Vertex Pharmaceuticals Incorporated Recent Developments
Table 106. GlaxoSmithKline Basic Information List
Table 107. GlaxoSmithKline Description and Business Overview
Table 108. GlaxoSmithKline Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 109. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of GlaxoSmithKline (2019-2024)
Table 110. GlaxoSmithKline Recent Developments
Table 111. AbbVie Basic Information List
Table 112. AbbVie Description and Business Overview
Table 113. AbbVie Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 114. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of AbbVie (2019-2024)
Table 115. AbbVie Recent Developments
Table 116. Roche Basic Information List
Table 117. Roche Description and Business Overview
Table 118. Roche Multidrug Resistant Bacteria Treatment Products, Services and Solutions
Table 119. Revenue (US$ Million) in Multidrug Resistant Bacteria Treatment Business of Roche (2019-2024)
Table 120. Roche Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Multidrug Resistant Bacteria Treatment Downstream Customers
Table 124. Multidrug Resistant Bacteria Treatment Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Multidrug Resistant Bacteria Treatment Product Picture
Figure 2. Global Multidrug Resistant Bacteria Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Multidrug Resistant Bacteria Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Multidrug Resistant Bacteria Treatment Report Years Considered
Figure 5. Global Multidrug Resistant Bacteria Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Multidrug Resistant Bacteria Treatment Revenue in 2023
Figure 7. Multidrug Resistant Bacteria Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Oral Picture
Figure 9. Parenteral Picture
Figure 10. Others Picture
Figure 11. Global Multidrug Resistant Bacteria Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Multidrug Resistant Bacteria Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospital
Figure 14. Product Picture of Special Clinic
Figure 15. Product Picture of Recovery Center
Figure 16. Global Multidrug Resistant Bacteria Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Multidrug Resistant Bacteria Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Multidrug Resistant Bacteria Treatment Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Multidrug Resistant Bacteria Treatment Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Multidrug Resistant Bacteria Treatment Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Multidrug Resistant Bacteria Treatment Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Multidrug Resistant Bacteria Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Multidrug Resistant Bacteria Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Multidrug Resistant Bacteria Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Multidrug Resistant Bacteria Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Multidrug Resistant Bacteria Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Multidrug Resistant Bacteria Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Multidrug Resistant Bacteria Treatment Sales Value (%), (2019-2030)
Figure 29. United States Multidrug Resistant Bacteria Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Multidrug Resistant Bacteria Treatment Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Multidrug Resistant Bacteria Treatment Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Multidrug Resistant Bacteria Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Multidrug Resistant Bacteria Treatment Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Multidrug Resistant Bacteria Treatment Sales Value by Application (%), 2023 VS 2030
Figure 35. China Multidrug Resistant Bacteria Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Multidrug Resistant Bacteria Treatment Sales Value by Type (%), 2023 VS 2030
Figure 37. China Multidrug Resistant Bacteria Treatment Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Multidrug Resistant Bacteria Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Multidrug Resistant Bacteria Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Multidrug Resistant Bacteria Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Multidrug Resistant Bacteria Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Multidrug Resistant Bacteria Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Multidrug Resistant Bacteria Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Multidrug Resistant Bacteria Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Multidrug Resistant Bacteria Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Multidrug Resistant Bacteria Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. India Multidrug Resistant Bacteria Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Multidrug Resistant Bacteria Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. India Multidrug Resistant Bacteria Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. Multidrug Resistant Bacteria Treatment Industrial Chain
Figure 51. Multidrug Resistant Bacteria Treatment Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
